Triclosan Coated Suture Wound Closure for Peripheral Vascular Surgery: a Prospective Multicenter Study

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Sanna Kouhia, North Carelia Central Hospital
ClinicalTrials.gov Identifier:
NCT01101789
First received: April 8, 2010
Last updated: January 3, 2012
Last verified: January 2012
  Purpose

This is a prospective randomized multicenter study which purpose is to determine whether triclosan-coated sutures for wound closure after lower limb vascular surgery would reduce the incidence of surgical wound infections.


Condition Intervention
Surgical Wound Infection
Procedure: triclosan coated suture for surgical wound closure

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
Official Title: Triclosan Coated Suture Wound Closure for Peripheral Vascular Surgery: a Prospective Multicenter Study

Resource links provided by NLM:


Further study details as provided by North Karelia Central Hospital:

Primary Outcome Measures:
  • surgical wound infection [ Time Frame: one month after surgical procedure ] [ Designated as safety issue: Yes ]

Enrollment: 276
Study Start Date: April 2010
Study Completion Date: January 2011
Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
Intervention Details:
    Procedure: triclosan coated suture for surgical wound closure
    triclosan coated suture for surgical wound closure
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patient undergoing peripheral vascular surgery procedure

Exclusion Criteria:

  • patients refusal
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01101789

Locations
Finland
North Carelia central hospital
Joensuu, Finland, 80210
Sponsors and Collaborators
North Karelia Central Hospital
Investigators
Study Director: Johanna Turtiainen, MD North Karelia Central Hospital
Principal Investigator: Kimmo Makinen Kuopio University Hospital
Principal Investigator: Maarit Venermo Helsinki University Central Hospital
Principal Investigator: Eija Saimanen South Carelia Central Hospital
Study Director: Ilkka Uurto Tampere University Hospital
  More Information

No publications provided

Responsible Party: Sanna Kouhia, MD, North Carelia Central Hospital
ClinicalTrials.gov Identifier: NCT01101789     History of Changes
Other Study ID Numbers: NKCH-surg-006
Study First Received: April 8, 2010
Last Updated: January 3, 2012
Health Authority: Finland: North Carelia central hospital, department of vascular surgery

Keywords provided by North Karelia Central Hospital:
surgical wound infection
triclosan-coated suture

Additional relevant MeSH terms:
Infection
Surgical Wound Infection
Wound Infection
Pathologic Processes
Postoperative Complications
Wounds and Injuries
Triclosan
Anti-Infective Agents
Anti-Infective Agents, Local
Antimetabolites
Fatty Acid Synthesis Inhibitors
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses

ClinicalTrials.gov processed this record on October 21, 2014